Routine Asthma Test More Reliable in the Morning and Has Seasonal Effects, Say Doctors Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming ...

Experts from the University of Manchester have found that if a person with asthma takes their brown inhaler between 3pm and 4pm, they may see symptoms improve. The research, published in the ...

Improvement seen in nocturnal lung function and overnight suppression of blood eosinophil counts with a dosage time of between 3 through 4pm. HealthDay News — Midafternoon dosing with ...

Research conducted by the University of New South Wales revealed children in Geelong, the Bellarine, and the Surf Coast were more likely to have asthma than in other areas of Australia.

However, the term "hypoxia," if it means a deficiency of oxygen supply to the body, is quite a different thing from hypoxemia. The term hypoxia should probably not be used so commonly or so glibly.

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...

AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma symptoms and to help prevent asthma ...

The following is a summary of “Association of eosinophil-to-monocyte ratio with asthma exacerbations in adults: a cross-sectional analysis of NHANES data,” published in the April 2025 issue of the BMC ...

For millions of people around the world, asthma is a constant struggle. It’s not just about wheezing or coughing—it’s a chronic condition where the immune system overreacts to harmless ...

On the basis of nearly 20 systematic reviews and databases, the authors conclude that LABA monotherapy significantly increases the risk of asthma-related adverse effects. We also conclude that the use ...